Insurers Push Again for Action on High COVID Test Prices

Just one day after the Biden administration extended the public health emergency (PHE) through mid-October, AHIP published a report arguing that price-gouging on COVID-19 tests continues to be a problem. Crucially, that issue was created when pandemic relief legislation removed health insurers’ ability to hold down out-of-network charges for COVID tests, the trade group says.

Health policy experts who have studied COVID test prices and pandemic relief legislation say that AHIP’s findings are not at all off base. However, there may be little chance of addressing insurers’ concerns anytime soon.

“The laws, as Congress enacted, very clearly encourage price gouging on COVID tests, so it’s no surprise that it continues,” says Loren Adler, associate director of the USC-Brookings Schaeffer Initiative for Health Policy.

0 Comments
© 2023 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

pills-in-dollar-sign
January 20

MA, Part D Plans Face New Premium Calculus With Drug Price Negotiation

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
January 20

News Briefs: Medicare Advantage Enrollment Hits 30M, but Isn’t Done Rising

READ MORE
magnifier-and-data
January 20

Report Offers Ways to Fix ‘Hot Mess’ of Health Plan Price Transparency Data

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today